Patents by Inventor Joseph Hirman

Joseph Hirman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF MOST BOTHERSOME SYMPTOM (MBS) ASSOCIATED WITH MIGRAINE USING ANTI-CGRP ANTIBODIES
    Publication number: 20240101653
    Abstract: Methods for treatment of most bothersome symptom (MBS) associated with migraine are provided. Exemplary methods provide improvement in MBS associated with migraine within 1 month of administration og anti-CGRP antibodies of the invention. Also provided are methods for improvement of patient impression of change (PGIC) associated with migraine. Exemplary methods comprise administration of an anti-CGRP antagonistic antibody to a patient in need thereof.
    Type: Application
    Filed: March 13, 2023
    Publication date: March 28, 2024
    Inventors: Roger K. Cady, Jeffrey T.L. Smith, Joseph Hirman
  • ACUTE TREATMENT AND RAPID TREATMENT OF HEADACHE USING ANTI-CGRP ANTIBODIES
    Publication number: 20240076359
    Abstract: Methods for rapid treatment of chronic migraine are provided. Exemplary methods provide relief from migraine within 24 hours of administration. Also provided are methods for acute treatment of migraine. Exemplary methods comprise administration of an anti-CGRP antagonist antibody to a patient in need thereof.
    Type: Application
    Filed: February 23, 2023
    Publication date: March 7, 2024
    Inventors: Roger K. Cady, Jeffrey T.L. Smith, Joseph Hirman, Barbara Schaeffler, Lahar Mehta
  • TREATMENT OF HEADACHE USING ANTI-CGRP ANTIBODIES
    Publication number: 20240067708
    Abstract: Methods for immediate relief of migraine or headache are provided comprising the administration of an anti-CGRP antagonist antibody to a patient in need thereof.
    Type: Application
    Filed: February 23, 2023
    Publication date: February 29, 2024
    Inventors: Roger K. Cady, Jeffrey T.L. Smith, Joseph Hirman, Barbara Schaeffler, Lahar Mehta
  • Treatment of headache using anti-CGRP antibodies
    Patent number: 11639381
    Abstract: Methods for immediate relief of migraine or headache are provided comprising the administration of an anti-CGRP antagonist antibody to a patient in need thereof.
    Type: Grant
    Filed: February 18, 2020
    Date of Patent: May 2, 2023
    Assignee: H. LUNDBECK A/S
    Inventors: Roger K. Cady, Jeffrey T. L. Smith, Joseph Hirman, Barbara Schaeffler, Lahar Mehta
  • Acute treatment and rapid treatment of headache using anti-CGRP antibodies
    Patent number: 11639380
    Abstract: Methods for rapid treatment of chronic migraine are provided. Exemplary methods provide relief from migraine within 24 hours of administration. Also provided are methods for acute treatment of migraine. Exemplary methods comprise administration of an anti-CGRP antagonist antibody to a patient in need thereof.
    Type: Grant
    Filed: January 8, 2020
    Date of Patent: May 2, 2023
    Assignee: H. LUNDBECK A/S
    Inventors: Roger K. Cady, Jeffrey T. L. Smith, Joseph Hirman, Barbara Schaeffler, Lahar Mehta
  • TREATMENT OF HEADACHE USING ANTI-CGRP ANTIBODIESHEREOF
    Publication number: 20220251178
    Abstract: Methods for immediate relief of migraine or headache are provided comprising the administration of an anti-CGRP antagonist antibody to a patient in need thereof. This invention pertains to methods of treatment of headache disorders, such as migraine, using antibodies and fragments thereof (including Fab fragments) that specifically bind to human Calcitonin Gene Related Peptide (hereinafter “CGRP”).
    Type: Application
    Filed: February 18, 2020
    Publication date: August 11, 2022
    Inventors: Roger K. CADY, Jeffrey T.L. SMITH, Joseph HIRMAN, Barbara SCHAEFFLER, Lahar MEHTA
  • TREATMENT OF MOST BOTHERSOME SYMPTOM (MBS) ASSOCIATED WITH MIGRAINE USING ANTI-CGRP ANTIBODIES
    Publication number: 20210309725
    Abstract: Methods for treatment of most bothersome symptom (MBS) associated with migraine are provided. Exemplary methods provide improvement in MBS associated with migraine within 1 month of administration og anti-CGRP antibodies of the invention. Also provided are methods for improvement of patient impression of change (PGIC) associated with migraine. Exemplary methods comprise administration of an anti-CGRP antagonistic antibody to a patient in need thereof.
    Type: Application
    Filed: April 28, 2020
    Publication date: October 7, 2021
    Inventors: Roger K. Cady, Jeffrey T.L. Smith, Joseph Hirman
  • TREATMENT OF HEADACHE USING ANTI-CGRP ANTIBODIES
    Publication number: 20200299368
    Abstract: Methods for immediate relief of migraine or headache are provided comprising the administration of an anti-CGRP antagonist antibody to a patient in need thereof.
    Type: Application
    Filed: February 18, 2020
    Publication date: September 24, 2020
    Inventors: Roger K. Cady, Jeffrey T.L. Smith, Joseph Hirman, Barbara Schaeffler
  • ACUTE TREATMENT AND RAPID TREATMENT OF HEADACHE USING ANTI-CGRP ANTIBODIES
    Publication number: 20200216524
    Abstract: Methods for rapid treatment of chronic migraine are provided. Exemplary methods provide relief from migraine within 24 hours of administration. Also provided are methods for acute treatment of migraine. Exemplary methods comprise administration of an anti-CGRP antagonist antibody to a patient in need thereof.
    Type: Application
    Filed: January 8, 2020
    Publication date: July 9, 2020
    Inventors: Roger K. Cady, Jeffrey T.L. Smith, Joseph Hirman, Barbara Schaeffler
  • TREATMENT OF MEDICATION OVERUSE HEADACHE USING ANTI-CGRP OR ANTI-CGRP-R ANTIBODIES
    Publication number: 20200216525
    Abstract: Methods for treatment or prevention of medication overuse headache are provided. Exemplary methods comprise administration of an anti-CGRP antagonist antibody to a patient in need thereof.
    Type: Application
    Filed: January 8, 2020
    Publication date: July 9, 2020
    Inventors: Roger K. Cady, Jeffrey T.L. Smith, Joseph Hirman, Barbara Schaeffler